Exercise for Sarcopenia: When Protein Adds the Most

For sarcopenia, the best plan depends on the problem you want to improve. Resistance training appears to matter most for walking speed and mobility. Adding protein supplementation produces the largest handgrip-strength gains. Muscle mass is the harder sell: combined exercise and nutrition improved skeletal muscle index against passive control, but it did not consistently beat exercise alone.

That distinction gets lost when every intervention is compressed into "exercise plus protein works." It does work for some outcomes. But an older adult trying to walk faster, rise from a chair more easily, or preserve muscle mass does not necessarily need the same emphasis. The evidence supports a decision tree, not a universal stack of powders, pills, and optimism.

Start with resistance training, then match the add-ons to the goal

A 2023 systematic review and meta-analysis by Park et al. pooled 32 randomized controlled trials involving 3,063 older adults. It compared resistance exercise, nutritional supplementation, their combination, and passive control across skeletal muscle index (SMI), handgrip strength, and gait speed.

Combined exercise plus nutrition was the only comparison that significantly improved all three markers versus passive control: SMI increased by 0.20 kg/m², handgrip strength by 1.56 kg, and gait speed by 0.08 m/s. Those are pooled average differences during the intervention period, not guarantees for an individual patient.

The study's more useful finding lies in the active comparisons. Against exercise alone, combined treatment favored handgrip by 0.38 kg and gait speed by 0.12 m/s, while the SMI difference was not statistically significant. The same functional-only pattern appeared when combined treatment was compared with nutrition alone. Exercise alone beat passive control for handgrip strength by 1.74 kg and gait speed by 0.11 m/s, but not for SMI. Nutrition alone improved handgrip by 0.90 kg, with no significant effect on SMI or gait speed.

Exercise is the foundation. Protein is most defensible as an adjunct when strength is the priority, rather than as a substitute for training.

If mobility is the priority, train first

Gait speed is one of the clearest places where the ranking matters. In Park et al., exercise alone improved gait speed by 0.11 m/s versus passive control. That exceeds the commonly cited 0.1 m/s minimum clinically important difference. The combined intervention improved gait speed by 0.08 m/s versus control, a statistically significant result but below that clinical threshold.

This does not prove that protein harms walking performance or that combined treatment is inferior for every person. The pairwise comparisons drew on different subsets of trials, so their weighted mean differences cannot be treated as arithmetic building blocks. Still, the finding supports a practical conclusion: when the immediate aim is better mobility, do not delay resistance training while searching for the perfect supplement.

Exercise type also matters. A 2023 network meta-analysis by Zeng et al. found that resistance training outperformed aerobic exercise for muscle strength in older adults with sarcopenia. Multicomponent programs that combined resistance, balance, and aerobic exercise delivered the broadest functional profile. That makes sense for a person whose real-world goal is to walk, climb stairs, recover balance, and carry groceries—not merely improve one test score.

If strength is the priority, add protein—but keep expectations calibrated

Combined resistance training and nutritional supplementation produced the largest handgrip gain in Park et al.: 1.56 kg versus passive control and 0.38 kg beyond exercise alone. A 2024 meta-analysis of whey protein with or without resistance training also found that whey plus resistance training improved handgrip strength and SMI more than either approach alone.

Whey is therefore a reasonable default protein vehicle for an older adult already doing progressive resistance training. Leucine-enriched products are plausible alternatives, but the evidence does not establish one validated leucine dose for sarcopenia outcomes. A 2025 leucine meta-analysis identified leucine as an anabolic trigger while also reporting contradictory findings across studies. A 2025 randomized trial of BCAA-rich supplementation plus resistance training found better SMI and handgrip outcomes than resistance training alone in older patients with sarcopenia, but one trial cannot settle whether BCAAs outperform whey or leucine-enriched protein more broadly.

For total daily protein, a 12-week multicentre randomized trial by Sun et al. provided a mechanistic rationale for roughly 1.2 to 1.5 g/kg/day in older adults. The paper reports that older adults may require approximately 68% to 140% more protein than younger adults to maximally stimulate muscle protein synthesis. That target remains an inference from muscle-protein-synthesis physiology, not a directly established dose-response threshold for reversing sarcopenia.

People with chronic kidney disease or other conditions requiring protein restriction should set a target with their clinician. Sarcopenia care has enough moving parts already; adding an avoidable medical complication would be a poor trade.

Muscle mass may respond less than function

SMI is a muscle-mass marker, not a direct measure of independence, falls, or quality of life. In Park et al., combined treatment improved SMI by 0.20 kg/m² only when compared with passive control. It did not significantly improve SMI over exercise alone, nutrition alone, or in the other active comparisons.

A 2026 systematic review of resistance training plus amino acid-based supplements similarly found better functional outcomes with the combined approach but attenuating returns for muscle mass among people already performing structured resistance training. One possible interpretation is that adequate resistance training supplies much of the mechanical stimulus needed for muscle protein synthesis, leaving less room for supplements to add measurable mass. That remains an interpretation, not proof of a single biological ceiling.

For someone focused on SMI, resistance training still belongs at the center of the plan. Protein can support overall nutritional adequacy and may improve strength, but current pooled evidence does not show a reliable mass advantage from adding it to a structured exercise program.

A practical training template

The evidence base converges on a conventional progressive resistance program rather than a boutique protocol. The 2026 review describes training two to three times weekly at roughly 60% to 80% of one-repetition maximum, using two to three sets of eight to 12 repetitions for major muscle groups. Add balance work or aerobic exercise when broader physical function matters.

• For walking speed and mobility: prioritize progressive resistance training; include balance and aerobic work where appropriate.
• For handgrip strength and daily-task capacity: use resistance training and consider whey-based protein to help meet a daily protein target of roughly 1.2 to 1.5 g/kg.
• For muscle mass: expect modest, uncertain gains beyond training alone; track strength and function alongside SMI.
• For vitamin D: correct confirmed deficiency, but do not expect routine high-dose supplementation to reverse sarcopenia.

A 2021 network meta-analysis of vitamin D strategies found modest independent effects, mainly in people who began deficient. Vitamin D belongs in deficiency treatment, not in a generic "muscle-building" supplement pile.

The evidence has important cracks

Park et al.'s accessible abstract does not report confidence intervals or I² heterogeneity statistics for its pooled estimates. That means readers cannot assess their precision or how consistent the trials were without the full forest plots. The average intervention duration also is not reported there, which limits conclusions about how quickly benefits arise or how long they persist.

The diagnostic criteria varied across trials, including European and Asian definitions of sarcopenia. A 2025 network meta-analysis by Zhao et al. modeled exercise and nutrition strategies simultaneously using EWGSOP and AWGS criteria. This approach is better suited to ranking several treatment arms than separate pairwise comparisons, particularly when different comparisons contain different trial subsets.

Most importantly, gains require maintenance. In a 2022 randomized trial with 24 weeks of follow-up, improvements from leucine-enriched whey protein plus resistance training substantially reversed after de-training. A protocol that ends when the study ends is not a maintenance plan.

The bottom line is refreshingly unglamorous: lift regularly, eat enough protein to support the work, add balance and aerobic training when function calls for it, and keep doing it. Supplements can sharpen a strength-focused program. They cannot do the repetitions for you.